The use of digital pathology and image analysis in clinical trials

by Robert Pell, Karin Oien, Max Robinson, Helen Pitman, Nasir Rajpoot, Jens Rittscher, David Snead, Clare Verrill, on behalf of the UK National Cancer Research Institute (NCRI) Cellular‐Molecular Pathology (CM‐Path) quality assurance working group
Published 2019-04-01